UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q/A
(Amendment No. 1)
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2011
or
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
FOR THE TRANSITION PERIOD FROM ___________ TO ______________
COMMISSION FILE NUMBER: 001-09727
PATIENT SAFETY TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
|
Delaware
|
|
13-3419202
|
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
| |
|
|
|
2 Venture Plaza, Suite 350, Irvine, CA 92618
|
|
(Address of principal executive offices) (Zip Code)
|
Registrant’s telephone number, including area code: (949) 387-2277
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:
|
Large accelerated filer ¨
|
Accelerated filer ¨
|
|
Non-accelerated filer ¨ (Do not check if smaller reporting company)
|
Smaller Reporting Company x
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ¨ No x
The number of outstanding shares of the registrant’s common stock, par value $0.33 per share, as of August 1, 2011 was 33,660,255.
Explanatory Note
The sole purpose of this Amendment No. 1 to the Registrant’s Quarterly Report on Form 10-Q for the quarterly period ending June 30, 2011, originally filed with the Securities and Exchange Commission on August 15, 2011 (the “Form 10-Q”), is to furnish Exhibit 101 to the Form 10-Q in accordance with Rule 405 of Regulation S-T. Exhibit 101 provides the financial statements and related notes from the Form 10-Q formatted in XBRL (eXtensible Business Reporting Language).
No other changes have been made to the Form 10-Q. This Amendment No. 1 to the Form 10-Q speaks as of the original filing date of the Form 10-Q, does not reflect events that may have occurred after the original filing date, and does not modify or update in any way the disclosures made in the original Form 10-Q.
SIGNATURE
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |
|
PATIENT SAFETY TECHNOLOGIES, INC.
|
|
Date: August 22, 2011
|
|
|
|
| |
|
|
|
| |
|
By:
|
/s/ David Dreyer
|
| |
|
|
David Dreyer, Executive Vice President,
|
| |
|
|
Chief Financial Officer, and Secretary
|
PART II – OTHER INFORMATION
|
Exhibit
Number
|
|
Description
|
|
31.1*
|
|
Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a)
|
| |
|
|
|
31.2*
|
|
Certification of Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a)
|
| |
|
|
|
32.1*
|
|
Certification of Chief Executive Officer and Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code
|
|
EX-101.INS**
|
XBRL Instance document
|
| |
|
|
EX-101.SCH**
|
XBRL Taxonomy Extension Schema Document
|
| |
|
|
EX-101.CAL**
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
| |
|
|
EX-101.DEF**
|
XBRL Taxonomy Extension Definition Linkbase Document
|
| |
|
|
EX-101.LAB**
|
XBRL Taxonomy Extension Label Linkbase Document
|
| |
|
|
EX-101.PRE**
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
| |
|
|
*
|
These exhibits were previously included or incorporated by reference in Patient Safety Technologies, Inc. Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2011, filed with the Securities and Exchange Commission on August 15, 2011.
|
|
**
|
Filed herewith. Pursuant to Rule 406T of Regulation S-T, the XBRL related information in Exhibit 101 to the Quarterly Report on Form 10-Q is deemed not filed or part of a registration statement or prospectus for purposes of Section 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.
|